If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
387.50    -8.50 (-2.15%)
Bid:
387.00
Ask:
393.00
Spread: 6.00 (1.55%)
Market Cap: £1.76b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Acquisition

18 Sep 2008 11:48

RNS Number : 7452D
HG Capital Trust PLC
18 September 2008
 



HgCapital Trust plc

The following is the text of a press release issued by HgCapital, which manages the investment portfolio of HgCapital Trust plc alongside those of other institutional clients. The Trust, which is a listed investment trust giving investors the opportunity to participate in all of HgCapital's investments, will invest approximately £5.5 million in KVT.

HgCapital and Capvis agree to invest in KVT

Zurich/Munich, 18 September 2008 - Swiss private equity firm Capvis and European private equity investor HgCapital have agreed to become investors in Koenig Verbindungstechnik AG (KVT), the Swiss fastenings and sealing technology products group., Capvis originally acquired KVT Group for € 325 million from Debrunner Koenig Holding AG, a fully owned subsidiary of German listed Klöckner & Co SE, in July.

Under the terms of the agreement Capvis and HgCapital will enjoy equal rights as investors. The transaction is subject to approval by the relevant competition authorities.

KVT is a leading supplier of fastening and sealing technology products. The company sells force fitting fasteners, rivet systems, screw threads, adhesive products, related automation solutions and expanders for hydraulics and automotive applications. KVT's products are primarily used in the engineering, automotive, electronics and transportation industries as well as in the medical engineering, aerospace and construction industries.

KVT manufactures fastenings at its headquarters in Dietikon in Switzerland and operates distribution companies in GermanyAustriaPoland, the Czech Republic and the US. The company employs over 300 people worldwide and generated sales of approximately 120 million in 2007, continuing the strong growth of recent years. Capvis and HgCapital see further growth potential from attracting additional customers, particularly in the global automotive industry.

Michael Bauer from Capvis commented: 

"We are delighted to have found an additional strong partner for KVT in HgCapital, which shares our investment philosophy. Together, we will support KVT's management in its focused international expansion. We are convinced that KVT will extend its market position in existing markets and successfully expand in new markets in the coming years."

Justin von Simson from HgCapital said: 

"KVT is exactly the type of business that HgCapital likes to invest in. It is highly profitable and has above average growth rates and fits within our specialist industrials investment sector. We look forward to working with Capvis to support KVT and its management to accelerate the group's growth following its buyout from the Klöckner Group."

Ends

About Capvis

Capvis is the leading private equity firm in Switzerland and among the market leaders in German-speaking Europe. Capvis invests in well-positioned mid-sized companies with significant operations in SwitzerlandGermany or Austria, typically as part of succession solutions and corporate spin-offs. Capvis aims to work together with management to release sustainable business potential and to lead its investment companies to a new level of excellence. Capvis Funds currently total EUR 900 million. Since 1990, the Capvis team has conducted 39 transactions with a volume of more than EUR 3.0 billion. 

For further details, see www.capvis.com

About HgCapital

HgCapital is a private-equity investor in the European mid-market. We focus on investments with an enterprise value in the range of  75 -  750 million. Our business model combines sector specialisation with dedicated, proactive support to our portfolio companies as well as the application of significant human resource and the corresponding management expertise across all phases of the investment process. HgCapital manages more than  2.0 billion for some of the world's leading institutional and private investors. Our goal is to achieve outstanding results for our investors, management team and intermediaries.

For further details, see www.hgcapital.com

Further information:

Contacts:

Capvis

Michael Bauer

Tel: +41 43 300 58 58

HgCapital 

Justin von Simson

Tel: +49 89 255 49 55 15

Maitland (UK Press)

Neil Bennett

Tel: +44 (0)20 7379 5151

Hering-Schuppener (German Press)

Georg Jakobs

Tel: +49 (69) 92 18 74 76


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUWSRRWVRKAAR
Date   Source Headline
18th Sep 20237:00 amRNSHalf-year Report and Dividend Declaration
5th Sep 20238:00 amRNSHg agrees to sale of Commify to ECI Partners
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.